Diabetes mellitus ve komplikasyonlarının tanı,tedavi ve izlem ...

19
Yararlan›lan kaynaklar
1. Abraira C, Duckworth WC, Moritz T. Glycaemic separation and risk factor control in the Veterans
Affairs Diabetes Trial: an interim report. Diabetes Obes Metab. 2009;11:150-6.
2. ACE/AACE Diabetes Road Map Task Force. Road maps to achieve glycaemic control in type 2 diabetes
mellitus. Endocrine Practice 2007;13:261-9.
3. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering
in type 2 diabetes. N Engl J Med 2008;358:2545-59.
4. ADA Clinical Practice Recommendations. ADA standards of medical care in diabetes-2007. Diabetes
Care 2007;30(Suppl.1):S4-S41.
5. ADA Clinical Practice Recommendations. Diagnosis and classification of diabetes mellitus. Diabetes
Care 2007;30(Suppl.1):S42-S47.
6. ADA Clinical Practice Recommendations. Standards of medical care. Diabetes Care 2008;31(Suppl.1):S12-
S54.
7. ADA Clinical Practice Recommendations. Standards of medical care. Diabetes Care 2009;32(Suppl.1):S13-
61.
8. ADA Position Statement. Hyperglycemic crises in diabetes. Diabetes Care 2004;27(Suppl.1):S94-S102.
9. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients
with type 2 diabetes. N Engl J Med 2008;358:2560-72.
10. American College of Physicians. ACP Diabetes Care Guide: A Team Based Practice Manual and Self
Assessment Program. ACP, Philadelphia, 2007.
11. American Diabetes Association Consensus Statement. DKA in infants, children and adolescents.
Diabetes Care 2006:29;1150-9.
12. American Diabetes Association Position Statement. Continuous subcutaneous insülin infusion. Diabetes
Care 2004;27(Suppl 1):S110.
13. American Diabetes Association Position Statement. Standards of medical care in diabetes-2006.
Diabetes Care 2006;29(Suppl 1):S4-S42.
14. American Diabetes Association. American Diabetes Association Complete Guide to Diabetes. 2nd
Edition. ADA, Alexandria, 1999.
15. American Diabetes Association. Clinical Practice Recommendations 2009. Diabetes Care
2009;32(Supplement 1):S1-98.
16. Armstrong DG, Lavery LA (Editors). Clinical Care of the Diabetic Foot. ADA Publ, Alexandria, 2005.
17. Bolan G, Broome CV, Facklam RR, et al. Pneumococcal vaccine efficacy in selected populations in
the United States. Ann Intern Med 1986;104:1-6.
18. Brown A, Mangione C, Saliba D, et al. Guidelines for improving the care of the older person with
diabetes mellitus. J Am Geriatr Soc 2003;51:S265-80.
19. Canadian Diabetes Association. 2003 Clinical Practice Guidelines for the Prevention and Management
of Diabetes in Canada. Canadian J Diabetes. 2003;27(Supplement 2).
20. Canadian Diabetes Association. 2008 Clinical Practice Guidelines for the Prevention and Management
of Diabetes in Canada. Canadian J Diabetes 2008;32(Suppl. 1):1-215.
21. CDC Diabetes Cost-Effectiveness Study Group. Cost-effectiveness of intensive glycemic control,
intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA
2002;287:2542-51.
22. Chobanian AV, . Bakris GL, Black HR, et al. The National High Blood Pressure Education Program
Coordinating Committee. JNC 7: Complete Report. Seventh Report of the Joint National Committee
on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension.
2003;42:1206-52.
DİABETES MELLİTUS VE KOMPLİKASYONLARININ TANI, TEDAVİ VE İZLEM KILAVUZU | 171